Agammaglobulinemia związana z chromosomem x – Charakterystyka, pielęgnacja i opieka

Agammaglobulinemia związana z chromosomem x
Charakterystyka, pielęgnacja i opieka

Agammaglobulinemia związana z chromosomem X (XLA) to genetyczny defekt spowodowany mutacją w genie BTK, prowadzący do braku produkcji przeciwciał i ciężkiego upośledzenia odporności humoralnej, co skutkuje zwiększoną podatnością na infekcje bakteryjne i wirusowe. Choroba dotyczy głównie chłopców i manifestuje się w pierwszym roku życia po zaniku przeciwciał matczynych. Podstawą leczenia jest dożywotnia terapia zastępcza immunoglobulinami (RIgG) w dawkach 400-600 mg/kg/miesiąc, podawana dożylnie (IVIG) lub podskórnie (SCIG), z celem utrzymania poziomu IgG na poziomie 500-800 mg/dl. Terapia powinna być rozpoczęta optymalnie w wieku 10-12 tygodni życia. Monitorowanie działań niepożądanych, takich jak bóle głowy, gorączka czy zmiany ciśnienia krwi, oraz dostosowanie parametrów infuzji są kluczowe dla bezpieczeństwa pacjenta.

Charakterystyka agammaglobulinemii związanej z chromosomem X

Agammaglobulinemia związana z chromosomem X (XLA), znana również jako agammaglobulinemia Brutona, jest rzadką chorobą genetyczną powodującą osłabienie układu odpornościowego. Jest spowodowana mutacją w genie BTK (Bruton’s tyrosine kinase), który znajduje się na chromosomie X. Z tego powodu choroba dotyka głównie chłopców, ponieważ posiadają oni tylko jeden chromosom X. Pacjenci z XLA nie są w stanie wytwarzać przeciwciał, które są częścią gamma globulin w osoczu krwi i stanowią główną ochronę organizmu przed drobnoustrojami.¹²

Brak zdolności do produkcji przeciwciał sprawia, że osoby z XLA są bardzo podatne na infekcje bakteryjne, wirusowe oraz przewlekłą biegunkę. Ta zwiększona podatność na infekcje staje się szczególnie widoczna w pierwszym roku życia, gdy przeciwciała matczyne zostają zmetabolizowane.³⁴

Opieka pielęgniarska w XLA

Opieka pielęgniarska nad pacjentami z agammaglobulinemią związaną z chromosomem X wymaga kompleksowego podejścia, obejmującego zarówno leczenie, jak i profilaktykę. Pomimo braku możliwości wyleczenia tej choroby, odpowiednie postępowanie medyczne pozwala większości pacjentów prowadzić normalne, aktywne życie.⁵⁶

Terapia zastępcza immunoglobulinami

Podstawą leczenia XLA jest dożywotnia terapia zastępcza immunoglobulinami (RIgG). Polega ona na podawaniu pacjentowi przeciwciał od dawców, co pomaga zastąpić przeciwciała, których organizm nie jest w stanie wytworzyć samodzielnie. Terapia ta może być prowadzona na dwa sposoby:⁷⁸

Dożylnie (IVIG) – przeciwciała są podawane bezpośrednio do żyły
Podskórnie (SCIG) – przeciwciała są wstrzykiwane pod skórę

⁹

Typowe dawki immunoglobulin wynoszą 400-600 mg/kg/miesiąc, podawane co 3-4 tygodnie. Dawki i odstępy między podaniami mogą być dostosowywane w zależności od indywidualnej odpowiedzi klinicznej pacjenta. Zaleca się utrzymywanie minimalnego poziomu IgG na poziomie 500-800 mg/dl. Terapię należy rozpocząć jak najwcześniej, optymalnie w wieku 10-12 tygodni życia.¹⁰

Wybór między terapią dożylną a podskórną zależy od indywidualnych potrzeb pacjenta i jego rodziny. Nie ma jednoznacznych dowodów na to, że jedna metoda podawania jest lepsza od drugiej.¹¹¹²

Monitorowanie i zarządzanie działaniami niepożądanymi terapii immunoglobulinowej

Terapia immunoglobulinowa, choć skuteczna, może powodować działania niepożądane, które wymagają starannego monitorowania. Najczęstsze działania niepożądane to:¹³

Bóle głowy
Gorączka
Bóle mięśni
Zmiany ciśnienia krwi
Nudności
Dyskomfort w klatce piersiowej

¹⁴

Lekarze mogą zarządzać tymi działaniami niepożądanymi poprzez modyfikację parametrów terapii, takich jak:¹⁵

Czas między infuzjami
Metoda podawania
Szybkość podawania
Konkretny produkt używany do terapii zastępczej

¹⁶

W przypadku bólów głowy, które są częstym natychmiastowym działaniem niepożądanym, można zastosować leki dostępne bez recepty oraz zmniejszyć szybkość infuzji.¹⁷

Leczenie i profilaktyka infekcji

Pacjenci z XLA są szczególnie podatni na infekcje bakteryjne i niektóre infekcje wirusowe. Dlatego ważnym elementem opieki jest szybkie rozpoznawanie i leczenie infekcji:¹⁸

Antybiotyki, takie jak amoksycylina i amoksycylina z kwasem klawulanowym, są stosowane w leczeniu typowych infekcji zatok i dróg oddechowych
W przypadku przewlekłych infekcji, zapalenia płuc lub sepsy można zastosować dożylny ceftriakson, w oczekiwaniu na wyniki posiewu
Ważne jest uzyskanie posiewów w celu określenia wrażliwości drobnoustrojów, ponieważ wiele organizmów wykazuje oporność u tej populacji pacjentów
Infekcje Streptococcus pneumoniae mogą wymagać ceftriaksonu, cefotaksymu lub wankomycyny

¹⁹

Oprócz antybiotyków, w leczeniu mogą być również potrzebne:²⁰

Leki rozszerzające oskrzela
Sterydy wziewne
Regularne testy funkcji płuc (co najmniej 3-4 razy w roku)

²¹

W przypadku przewlekłych objawów dermatologicznych, takich jak atopowe zapalenie skóry i egzema, stosuje się codzienne nawilżanie skóry i miejscowe sterydy.²²

Szczepienia i unikanie żywych szczepionek

Pacjenci z XLA nie powinni otrzymywać szczepionek zawierających żywe bakterie lub wirusy, ponieważ mogą one wywołać choroby, którym mają zapobiegać. Do szczepionek, których należy unikać, należą:²³²⁴

Szczepionka przeciwko polio (żywa)
Szczepionka przeciwko odrze, śwince i różyczce (MMR)
Szczepionka przeciwko ospie wietrznej
Szczepionka przeciwko rotawirusom

²⁵

Zaleca się natomiast wszystkie szczepionki, które nie zawierają żywych bakterii lub wirusów.²⁶

Plan opieki nad pacjentem z XLA

Regularne wizyty kontrolne

Pacjenci z XLA powinni regularnie odbywać wizyty kontrolne, zazwyczaj co 6-12 miesięcy, w celu monitorowania komplikacji związanych z chorobą.²⁷²⁸

Podczas tych wizyt lekarze mogą ocenić skuteczność terapii immunoglobulinowej, monitorować występowanie infekcji i dostosować leczenie w razie potrzeby. Regularne wizyty są również okazją do edukacji pacjenta i jego rodziny na temat choroby i jej zarządzania.²⁹

Edukacja pacjenta i rodziny

Edukacja pacjenta i jego rodziny jest kluczowym elementem opieki nad osobami z XLA. Pacjenci i ich rodziny powinni otrzymać materiały edukacyjne dotyczące:³⁰

Szczepień
Terapii zastępczej immunoglobulinami
Profilaktycznego i terapeutycznego stosowania antybiotyków
Rutynowej i nagłej opieki medycznej
Znaczenia regularnych wizyt kontrolnych
Zespołu specjalistów opieki zdrowotnej
Przygotowania do podróży
Znaczenia prowadzenia dokumentacji
Wsparcia
Jak być dobrym rzecznikiem pacjenta

³¹

Zapobieganie infekcjom

Pacjenci z XLA powinni przestrzegać dobrych praktyk zapobiegania infekcjom, takich jak:³²

Regularne mycie rąk
Unikanie kontaktu z osobami chorymi
Szybkie rozpoznawanie i leczenie objawów infekcji

³³

Ważne jest, aby pacjenci i ich rodziny potrafili rozpoznać objawy infekcji i wiedzieli, kiedy szukać pomocy medycznej.³⁴

Wsparcie psychospołeczne

Życie z przewlekłą chorobą, jaką jest XLA, może być wyzwaniem zarówno dla pacjenta, jak i jego rodziny. Dlatego ważne jest zapewnienie odpowiedniego wsparcia psychospołecznego.³⁵

Pacjenci z XLA mogą prowadzić w większości normalne życie i powinni być zachęcani do uczestnictwa w regularnych aktywnościach odpowiednich dla ich wieku. Jednakże, nawracające infekcje związane z XLA będą wymagały starannego monitorowania i leczenia, ponieważ mogą uszkodzić narządy i zagrażać życiu.³⁶³⁷

Współpraca ze szkołą i innymi placówkami

Ważne jest, aby informować szkołę dziecka i inne bliskie kontakty o jego stanie zdrowia. Współpraca z placówkami edukacyjnymi pomaga zapewnić dziecku bezpieczne środowisko i odpowiednie wsparcie.³⁸³⁹

Współpraca z lekarzem i szkołą w celu opracowania planu leczenia może pomóc dziecku prowadzić jak najbardziej normalne życie, jednocześnie zapewniając mu niezbędną opiekę medyczną.⁴⁰

Postępowanie w przypadku powikłań

Leczenie ostrych infekcji

Pacjenci z XLA są hospitalizowani w przypadku ciężkich infekcji lub ostrej dekompensacji. Interwencje chirurgiczne są ograniczone do ciężkich ostrych infekcji lub przewlekłych infekcji nieodpowiadających na leczenie.⁴¹

Najczęstsze procedury obejmują:⁴²

Leczenie pacjentów z nawracającym zapaleniem ucha środkowego poprzez wprowadzenie dreników
Leczenie pacjentów z przewlekłym zapaleniem zatok poprzez drenaż chirurgiczny

⁴³

Przed operacją pacjenci z XLA powinni otrzymać dożylnie immunoglobuliny, aby zapobiec infekcji.⁴⁴

Zarządzanie przewlekłymi powikłaniami

Częste powikłania XLA obejmują zapalenie ucha środkowego, zapalenie zatok i zapalenie płuc, które wymagają natychmiastowej oceny diagnostycznej i interwencji terapeutycznej, aby zapobiec dalszym powikłaniom.⁴⁵

Niektórzy pacjenci z XLA mogą mieć problemy żołądkowo-jelitowe, które mogą wymagać współpracy ze specjalistami gastroenterologii.⁴⁶

Mimo stosowania terapii zastępczej immunoglobulinami, u pacjentów z XLA nadal może rozwijać się przewlekła choroba płuc, a ogólna przeżywalność jest zmniejszona.⁴⁷

Wskazówki dotyczące stylu życia

Dieta i suplementacja

Pacjenci z XLA powinni przestrzegać normalnej diety uzupełnionej o multiwitaminy. Nie ma specyficznych ograniczeń dietetycznych dla XLA, chociaż dieta niskotłuszczowa może być potrzebna dla pacjentów z zapalną chorobą jelit.⁴⁸

Zaleca się suplementację żywieniową multiwitaminami.⁴⁹

Aktywność fizyczna

Pacjenci z XLA nie mają specyficznych ograniczeń fizycznych. Stanowczo zaleca się, aby pacjenci nie palili tytoniu i nie byli narażeni na dym, ze względu na zwiększone ryzyko infekcji zatok i dróg oddechowych.⁵⁰

Pacjenci powinni być zachęcani do uczestnictwa w regularnych aktywnościach odpowiednich dla ich wieku, co pomaga prowadzić jak najbardziej normalne życie.⁵¹

Interdyscyplinarne podejście do opieki

Opieka nad pacjentami z XLA wymaga interdyscyplinarnego podejścia zespołowego, które jest właściwą metodologią zarządzania.⁵²

Immunolodzy są dobrze przygotowani do leczenia chorób klinicznych związanych z XLA. Jeśli pacjent zdecyduje się na opiekę zdrowotną świadczoną przez lekarza podstawowej opieki zdrowotnej, lekarz ten powinien mieć szczególne zainteresowanie i doświadczenie w chorobach niedoboru odporności.⁵³

Wczesna diagnoza jest kluczowa dla zmniejszenia zachorowalności i śmiertelności pacjentów z XLA. Identyfikowanie specyficznych mutacji genowych odpowiedzialnych za XLA pozwala pracownikom służby zdrowia na zapewnienie ukierunkowanych terapii i interwencji do skutecznego zarządzania tym stanem.⁵⁴

Rokowanie i jakość życia

Większość dzieci z XLA, które są wcześnie leczone, może prowadzić normalne, aktywne życie.⁵⁵⁵⁶

Terapia zastępcza immunoglobulinami zmniejsza ryzyko inwazyjnych infekcji. Jednak nadal może rozwijać się przewlekła choroba płuc, a ogólna przeżywalność jest zmniejszona.⁵⁷

Rokowanie dla pacjentów z XLA może być korzystnie wpłynięte przez wczesną diagnozę i rozważne stosowanie terapii immunoglobulinowej.⁵⁸

Podsumowując, agammaglobulinemia związana z chromosomem X jest poważnym schorzeniem, które wymaga kompleksowej opieki medycznej. Dzięki odpowiedniemu leczeniu, edukacji i wsparciu, pacjenci z XLA mogą prowadzić w miarę normalne życie, uczestnicząc w regularnych aktywnościach odpowiednich dla ich wieku. Kluczem do sukcesu jest wczesna diagnoza, regularne wizyty kontrolne i przestrzeganie zaleceń dotyczących terapii zastępczej immunoglobulinami i zapobiegania infekcjom.⁵⁹⁶⁰

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

Materiały źródłowe

#1 X-Linked Agammaglobulinemia in Children
https://healthlibrary.umcno.org/Library/News/FocusonHealth/90,P01666
X-linked agammaglobulinemia is a rare genetic disease. It causes a weakened immune system. It is also known as Bruton’s agammaglobulinemia. X-linked means that the gene that causes this disease is located on the X chromosome. It mainly affects boys because they have only have one X chromosome. […] A child with this disease cant make antibodies that are part of gamma globulins in blood plasma. Antibodies are the body’s main defense against germs like bacteria and viruses. So a child with this disease cant fight off infections caused by bacteria and some viruses. […] Most children with this disease who are treated early can lead normal, active lives. […] Treatment may include replacing antibodies, treating and preventing infections, and not getting live virus vaccines. […] Keep in regular touch with your childs healthcare provider, and tell your childs school and other close contacts. This will help your child stay healthier.
#2 X-linked agammaglobulinemia â Knowledge and References â Taylor & Francis
https://taylorandfrancis.com/knowledge/Medicine_and_healthcare/Allergology_%26_clinical_immunology/X-linked_agammaglobulinemia/
X-linked agammaglobulinemia (XLA) is a genetic disease caused by mutations in the BTK gene, resulting in a deficiency of Btk tyrosine kinase. This deficiency leads to a lack of mature B cells and immunoglobulins, making individuals with XLA highly susceptible to infections, particularly during the first year of life when maternal immunoglobulins have been catabolized. […] X-linked agammaglobulinemia (XLA) is caused by a mutation of the Brutonâs tyrosine kinase in b-cells, patients with XLA have low or no measurable serum levels of all immunoglobin types. These patients need a lifelong substitution of immunoglobin and recurrent antibiotic therapy to prevent or to treat a potentially life-threatening bacterial infection. […] X-linked agammaglobulinemia (XLA), which was first described by Bruton in 1952, is caused by mutations in Brutonâs tyrosine kinase (BTK) gene. It is one of the most common primary immunodeficiency diseases (PIDs) that is characterized by an increased susceptibility to bacterial and enteroviral infections because of the absence of peripheral mature B cells and profound hypogammaglobulinemia. In addition to frequent and/or severe infections, autoimmune diseases can also be associated with XLA. However, owing to the defective production of antibodies, autoimmunity in XLA is observed less frequently than in the other PIDs.
#3 X-Linked Agammaglobulinemia – MD Searchlight
https://mdsearchlight.com/genetic-disorders/x-linked-agammaglobulinemia/?utm_source=pubmedlink&utm_campaign=MDS&utm_content=31430
X-Linked Agammaglobulinemia (XLA) is a frequent immune system disorder in children that prevents the creation of antibodies, making individuals highly susceptible to bacterial infections, viruses, and chronic diarrhea. […] Despite the lack of a cure for XLA, early treatment with immunoglobulin and antibiotics can prevent and manage infections. This lifelong treatment can be expensive, but it’s essential. […] While there isn’t a cure for XLA, or X-linked agammaglobulinemia, managing the condition involves preventing and managing infections. […] This disease management strategy involves several steps: First, regular treatment using immunoglobulin, which are proteins in your blood that fight infections. This is delivered through either an intravenous (IV) infusion, which means it’s injected directly into your veins, or a subcutaneous injection, which is given under your skin.
#4 X-linked agammaglobulinemia â Knowledge and References â Taylor & Francis
https://taylorandfrancis.com/knowledge/Medicine_and_healthcare/Allergology_%26_clinical_immunology/X-linked_agammaglobulinemia/
X-linked agammaglobulinemia (XLA) is a genetic disease caused by mutations in the BTK gene, resulting in a deficiency of Btk tyrosine kinase. This deficiency leads to a lack of mature B cells and immunoglobulins, making individuals with XLA highly susceptible to infections, particularly during the first year of life when maternal immunoglobulins have been catabolized. […] X-linked agammaglobulinemia (XLA) is caused by a mutation of the Brutonâs tyrosine kinase in b-cells, patients with XLA have low or no measurable serum levels of all immunoglobin types. These patients need a lifelong substitution of immunoglobin and recurrent antibiotic therapy to prevent or to treat a potentially life-threatening bacterial infection. […] X-linked agammaglobulinemia (XLA), which was first described by Bruton in 1952, is caused by mutations in Brutonâs tyrosine kinase (BTK) gene. It is one of the most common primary immunodeficiency diseases (PIDs) that is characterized by an increased susceptibility to bacterial and enteroviral infections because of the absence of peripheral mature B cells and profound hypogammaglobulinemia. In addition to frequent and/or severe infections, autoimmune diseases can also be associated with XLA. However, owing to the defective production of antibodies, autoimmunity in XLA is observed less frequently than in the other PIDs.
#5 X-Linked Agammaglobulinemia in Children
https://library.sarahbush.org/MentalHealth/90,P01666
Most children with X-linked agammaglobulinemia who are treated early can lead normal, active lives. […] Treatment may include replacing antibodies, treating and preventing infections, and not getting live virus vaccines. […] Keep in regular touch with your child’s healthcare provider, and tell your child’s school and other close contacts. This will help your child stay healthier.
#6 X-linked agammaglobulinemia | Beacon Health System
https://www.beaconhealthsystem.org/library/diseases-and-conditions/x-linked-agammaglobulinemia?content_id=CON-20256723
This genetic disease weakens the immune system, mainly in males, and leads to having infections often. […] People with XLA can live mostly typical lives. They should try to take part in regular activities for their ages. But repeat infections linked to XLA will likely need careful watching and treatment. They can damage organs and be life-threatening. […] There’s no cure for XLA. Treatment aims at boosting the immune system to prevent infections. There also is quick treatment for infections as they happen. […] Your healthcare professional likely will suggest that you have follow-up visits every 6 to 12 months to screen for complications of XLA. You’ll also likely be told to not get live vaccines, such as live polio, measles-mumps-rubella or chickenpox vaccines.
#7 X-Linked Agammaglobulinemia: Causes, Symptoms & Treatment
https://my.clevelandclinic.org/health/diseases/24955-x-linked-agammaglobulinemia
X-linked agammaglobulinemia (XLA) is a condition caused by a mutation in your BTK gene. Treatment for XLA includes antibody infusions. […] A healthcare provider can perform blood tests to determine whether you or your child have XLA. If test results show a low level of B-cells or antibodies, they’ll do genetic testing to look for DNA changes. […] There’s no cure for XLA. But treatments can help you or your child avoid serious illness. They include: Replacement immunoglobulins (RIgG). Your healthcare provider gives you donor antibodies in a vein. You’ll need this treatment at least once per month. […] The best way to take care of yourself with XLA is to prioritize your care. Keep appointments with your provider, and make sure you can recognize signs of an infection. Ask your provider what to do if you have symptoms of an infection. […] If you’re living with XLA a genetic condition where your body doesn’t make enough mature B-cells follow your healthcare provider’s guidance about when you may need care. It’s important that you can recognize signs of an infection so you can get treated as soon as possible.
#8 X-Linked (Bruton) Agammaglobulinemia Treatment & Management: Medical Care, Surgical Care, Consultations
https://emedicine.medscape.com/article/1050956-treatment
No curative therapy exists for X-linked agammaglobulinemia (XLA), or Bruton agammaglobulinemia. Treatment for XLA is IVIG. Typical doses are 400-600 mg/kg/mo given every 3-4 weeks. Doses and intervals can be adjusted based on individual clinical responses. Therapy should begin at age 10-12 weeks. Maintenance of an IgG trough level of 500-800 mg/dL is recommended. Therapy should be started at age 10-12 weeks. Currently, no evidence supports that one particular brand or route of administration (IV vs SC) is better than the other. […] Antibiotics, such as amoxicillin and amoxicillin/clavulanate, are administered for common sinopulmonary infections. Pending culture sensitivities, intravenous ceftriaxone may be used for chronic infections, pneumonia, or sepsis. When possible, cultures must be obtained to elucidate sensitivities; many organisms will show resistance in this population. Infections with Streptococcus pneumococcus, in particular, may require ceftriaxone, cefotaxime, or vancomycin for eradication.
#9 X-Linked Agammaglobulinemia – MD Searchlight
https://mdsearchlight.com/genetic-disorders/x-linked-agammaglobulinemia/
X-linked agammaglobulinemia or XLA is a frequent immune system disorder in children that stops them from creating antibodies, which are proteins that help fight off infections. People with this condition need lifelong treatment with an immune system protein called immunoglobulin to live healthily. […] Despite the lack of a cure for XLA, early treatment with immunoglobulin and antibiotics can prevent and manage infections. This lifelong treatment can be expensive, but its essential. […] While there isn’t a cure for XLA, or X-linked agammaglobulinemia, managing the condition involves preventing and managing infections. […] This disease management strategy involves several steps: First, regular treatment using immunoglobulin, which are proteins in your blood that fight infections. This is delivered through either an intravenous (IV) infusion, which means its injected directly into your veins, or a subcutaneous injection, which is given under your skin.
#10 X-Linked (Bruton) Agammaglobulinemia Treatment & Management: Medical Care, Surgical Care, Consultations
https://emedicine.medscape.com/article/1050956-treatment
No curative therapy exists for X-linked agammaglobulinemia (XLA), or Bruton agammaglobulinemia. Treatment for XLA is IVIG. Typical doses are 400-600 mg/kg/mo given every 3-4 weeks. Doses and intervals can be adjusted based on individual clinical responses. Therapy should begin at age 10-12 weeks. Maintenance of an IgG trough level of 500-800 mg/dL is recommended. Therapy should be started at age 10-12 weeks. Currently, no evidence supports that one particular brand or route of administration (IV vs SC) is better than the other. […] Antibiotics, such as amoxicillin and amoxicillin/clavulanate, are administered for common sinopulmonary infections. Pending culture sensitivities, intravenous ceftriaxone may be used for chronic infections, pneumonia, or sepsis. When possible, cultures must be obtained to elucidate sensitivities; many organisms will show resistance in this population. Infections with Streptococcus pneumococcus, in particular, may require ceftriaxone, cefotaxime, or vancomycin for eradication.
#11 X-Linked (Bruton) Agammaglobulinemia Treatment & Management: Medical Care, Surgical Care, Consultations
https://emedicine.medscape.com/article/1050956-treatment
No curative therapy exists for X-linked agammaglobulinemia (XLA), or Bruton agammaglobulinemia. Treatment for XLA is IVIG. Typical doses are 400-600 mg/kg/mo given every 3-4 weeks. Doses and intervals can be adjusted based on individual clinical responses. Therapy should begin at age 10-12 weeks. Maintenance of an IgG trough level of 500-800 mg/dL is recommended. Therapy should be started at age 10-12 weeks. Currently, no evidence supports that one particular brand or route of administration (IV vs SC) is better than the other. […] Antibiotics, such as amoxicillin and amoxicillin/clavulanate, are administered for common sinopulmonary infections. Pending culture sensitivities, intravenous ceftriaxone may be used for chronic infections, pneumonia, or sepsis. When possible, cultures must be obtained to elucidate sensitivities; many organisms will show resistance in this population. Infections with Streptococcus pneumococcus, in particular, may require ceftriaxone, cefotaxime, or vancomycin for eradication.
#12 X-linked agammaglobulinemia (XLA) – Children’s Health Immunology
https://www.childrens.com/specialties-services/conditions/xla
If your child is diagnosed with XLA, they will be treated with immunoglobulin IgG (antibodies) therapy on a regular basis for the rest of his life. IgG therapy can be given through a catheter in your childs vein (intravenous; IVIG) or subcutaneously (SCIG). The decision to use one or the other depends on whats best for your child and your family. There is currently no cure for XLA. […] Children with XLA should be followed at the center. If your child develops an infection, antibiotics can treat the infection. Some patients with XLA may have complications including gastrointestinal problems that may require cooperative interaction with gastroenterology specialists.
#13 X-Linked Agammaglobulinemia – MD Searchlight
https://mdsearchlight.com/genetic-disorders/x-linked-agammaglobulinemia/
Patients are also advised about the importance of getting all the vaccinations that don’t contain live bacteria or viruses. […] When dealing with immunoglobulin therapy, there are several factors to consider. Both intravenous (IVIG) and subcutaneous (SCIG) therapies are suitable, and the decision between the two depends on the specifics of each patient’s situation. […] The side effects of immunoglobulin therapy can vary but are often not severe and only temporary. Symptoms can include headaches, fever, muscle pain, changes in blood pressure, nausea, and chest discomfort. […] Patients with XLA rely on regular replacement of immunoglobulins, specific proteins that our immune system uses to fight off bacteria and viruses. While this treatment can improve life expectancy, reduce infection rates and severity, decrease the frequency of hospital visits, and lower the need for antibiotics, it also has its share of side effects that require diligent monitoring.
#14 X-Linked Agammaglobulinemia – MD Searchlight
https://mdsearchlight.com/genetic-disorders/x-linked-agammaglobulinemia/
Patients are also advised about the importance of getting all the vaccinations that don’t contain live bacteria or viruses. […] When dealing with immunoglobulin therapy, there are several factors to consider. Both intravenous (IVIG) and subcutaneous (SCIG) therapies are suitable, and the decision between the two depends on the specifics of each patient’s situation. […] The side effects of immunoglobulin therapy can vary but are often not severe and only temporary. Symptoms can include headaches, fever, muscle pain, changes in blood pressure, nausea, and chest discomfort. […] Patients with XLA rely on regular replacement of immunoglobulins, specific proteins that our immune system uses to fight off bacteria and viruses. While this treatment can improve life expectancy, reduce infection rates and severity, decrease the frequency of hospital visits, and lower the need for antibiotics, it also has its share of side effects that require diligent monitoring.
#15 X-Linked Agammaglobulinemia – MD Searchlight
https://mdsearchlight.com/genetic-disorders/x-linked-agammaglobulinemia/
Doctors can manage these side effects by altering parameters involved in the immunoglobulin replacement therapy, such as the time between infusions, the method of administration, the delivery rate, and the specific product used for replacement. […] Possible complications from the immunoglobulin replacement therapy include immediate reactions like headaches, which can be managed with over-the-counter medication and may be avoided by reducing the rate of infusion. […] Further side effects may include nausea, discomfort, fever, chest tightness, and migraines. […] Keeping records of all aspects of patient care, care management, and follow-up details is encouraged.
#16 X-Linked Agammaglobulinemia – MD Searchlight
https://mdsearchlight.com/genetic-disorders/x-linked-agammaglobulinemia/
Doctors can manage these side effects by altering parameters involved in the immunoglobulin replacement therapy, such as the time between infusions, the method of administration, the delivery rate, and the specific product used for replacement. […] Possible complications from the immunoglobulin replacement therapy include immediate reactions like headaches, which can be managed with over-the-counter medication and may be avoided by reducing the rate of infusion. […] Further side effects may include nausea, discomfort, fever, chest tightness, and migraines. […] Keeping records of all aspects of patient care, care management, and follow-up details is encouraged.
#17 X-Linked Agammaglobulinemia – MD Searchlight
https://mdsearchlight.com/genetic-disorders/x-linked-agammaglobulinemia/
Doctors can manage these side effects by altering parameters involved in the immunoglobulin replacement therapy, such as the time between infusions, the method of administration, the delivery rate, and the specific product used for replacement. […] Possible complications from the immunoglobulin replacement therapy include immediate reactions like headaches, which can be managed with over-the-counter medication and may be avoided by reducing the rate of infusion. […] Further side effects may include nausea, discomfort, fever, chest tightness, and migraines. […] Keeping records of all aspects of patient care, care management, and follow-up details is encouraged.
#18 X-Linked (Bruton) Agammaglobulinemia Treatment & Management: Medical Care, Surgical Care, Consultations
https://emedicine.medscape.com/article/1050956-treatment
No curative therapy exists for X-linked agammaglobulinemia (XLA), or Bruton agammaglobulinemia. Treatment for XLA is IVIG. Typical doses are 400-600 mg/kg/mo given every 3-4 weeks. Doses and intervals can be adjusted based on individual clinical responses. Therapy should begin at age 10-12 weeks. Maintenance of an IgG trough level of 500-800 mg/dL is recommended. Therapy should be started at age 10-12 weeks. Currently, no evidence supports that one particular brand or route of administration (IV vs SC) is better than the other. […] Antibiotics, such as amoxicillin and amoxicillin/clavulanate, are administered for common sinopulmonary infections. Pending culture sensitivities, intravenous ceftriaxone may be used for chronic infections, pneumonia, or sepsis. When possible, cultures must be obtained to elucidate sensitivities; many organisms will show resistance in this population. Infections with Streptococcus pneumococcus, in particular, may require ceftriaxone, cefotaxime, or vancomycin for eradication.
#19 X-Linked (Bruton) Agammaglobulinemia Treatment & Management: Medical Care, Surgical Care, Consultations
https://emedicine.medscape.com/article/1050956-treatment
No curative therapy exists for X-linked agammaglobulinemia (XLA), or Bruton agammaglobulinemia. Treatment for XLA is IVIG. Typical doses are 400-600 mg/kg/mo given every 3-4 weeks. Doses and intervals can be adjusted based on individual clinical responses. Therapy should begin at age 10-12 weeks. Maintenance of an IgG trough level of 500-800 mg/dL is recommended. Therapy should be started at age 10-12 weeks. Currently, no evidence supports that one particular brand or route of administration (IV vs SC) is better than the other. […] Antibiotics, such as amoxicillin and amoxicillin/clavulanate, are administered for common sinopulmonary infections. Pending culture sensitivities, intravenous ceftriaxone may be used for chronic infections, pneumonia, or sepsis. When possible, cultures must be obtained to elucidate sensitivities; many organisms will show resistance in this population. Infections with Streptococcus pneumococcus, in particular, may require ceftriaxone, cefotaxime, or vancomycin for eradication.
#20 X-Linked (Bruton) Agammaglobulinemia Treatment & Management: Medical Care, Surgical Care, Consultations
https://emedicine.medscape.com/article/1050956-treatment
Bronchodilators, steroid inhalers, and regular pulmonary function tests (at least 3-4 times a year) may be a required part of therapy in addition to antibiotics. […] Chronic dermatologic manifestations of atopic dermatitis and eczema are controlled with daily moisturizing lotions and topical steroids. […] Nutritional supplementation with multivitamins is recommended. […] Patients with X-linked agammaglobulinemia (XLA), or Bruton agammaglobulinemia, are hospitalized for severe infections or acute decompensation. […] Immunologists are well equipped to treat the clinical illnesses of XLA. If a patient chooses to have health care provided by a primary care physician, the physician should have a special interest and experience in immunodeficiency diseases. […] Surgical intervention for X-linked agammaglobulinemia (XLA) is limited to severe acute infections or unresponsive chronic infections. The most common procedures involve treating patients with recurrent otitis by inserting tympanostomy tubes and treating patients with chronic sinusitis by surgical drainage.
#21 X-Linked (Bruton) Agammaglobulinemia Treatment & Management: Medical Care, Surgical Care, Consultations
https://emedicine.medscape.com/article/1050956-treatment
Bronchodilators, steroid inhalers, and regular pulmonary function tests (at least 3-4 times a year) may be a required part of therapy in addition to antibiotics. […] Chronic dermatologic manifestations of atopic dermatitis and eczema are controlled with daily moisturizing lotions and topical steroids. […] Nutritional supplementation with multivitamins is recommended. […] Patients with X-linked agammaglobulinemia (XLA), or Bruton agammaglobulinemia, are hospitalized for severe infections or acute decompensation. […] Immunologists are well equipped to treat the clinical illnesses of XLA. If a patient chooses to have health care provided by a primary care physician, the physician should have a special interest and experience in immunodeficiency diseases. […] Surgical intervention for X-linked agammaglobulinemia (XLA) is limited to severe acute infections or unresponsive chronic infections. The most common procedures involve treating patients with recurrent otitis by inserting tympanostomy tubes and treating patients with chronic sinusitis by surgical drainage.
#22 X-Linked (Bruton) Agammaglobulinemia Treatment & Management: Medical Care, Surgical Care, Consultations
https://emedicine.medscape.com/article/1050956-treatment
Bronchodilators, steroid inhalers, and regular pulmonary function tests (at least 3-4 times a year) may be a required part of therapy in addition to antibiotics. […] Chronic dermatologic manifestations of atopic dermatitis and eczema are controlled with daily moisturizing lotions and topical steroids. […] Nutritional supplementation with multivitamins is recommended. […] Patients with X-linked agammaglobulinemia (XLA), or Bruton agammaglobulinemia, are hospitalized for severe infections or acute decompensation. […] Immunologists are well equipped to treat the clinical illnesses of XLA. If a patient chooses to have health care provided by a primary care physician, the physician should have a special interest and experience in immunodeficiency diseases. […] Surgical intervention for X-linked agammaglobulinemia (XLA) is limited to severe acute infections or unresponsive chronic infections. The most common procedures involve treating patients with recurrent otitis by inserting tympanostomy tubes and treating patients with chronic sinusitis by surgical drainage.
#23 X-linked agammaglobulinemia | Beacon Health System
https://www.beaconhealthsystem.org/library/diseases-and-conditions/x-linked-agammaglobulinemia?content_id=CON-20256723
This genetic disease weakens the immune system, mainly in males, and leads to having infections often. […] People with XLA can live mostly typical lives. They should try to take part in regular activities for their ages. But repeat infections linked to XLA will likely need careful watching and treatment. They can damage organs and be life-threatening. […] There’s no cure for XLA. Treatment aims at boosting the immune system to prevent infections. There also is quick treatment for infections as they happen. […] Your healthcare professional likely will suggest that you have follow-up visits every 6 to 12 months to screen for complications of XLA. You’ll also likely be told to not get live vaccines, such as live polio, measles-mumps-rubella or chickenpox vaccines.
#24 X-linked-agammaglobulinaemia
https://dermnetnz.org/topics/x-linked-agammaglobulinaemia
There is no cure for X-linked agammaglobulinaemia. However, treatment can greatly improve quality of life for X-linked agammaglobulinaemia patients. […] Life-long immunoglobulin replacement therapy, given intravenously or subcutaneously. This helps replace antibodies an X-linked agammaglobulinaemia patient cannot make for themselves. […] Antibiotics sometimes used prophylactically to reduce infection rates. […] Avoid live vaccines including measles, mumps, and rubella (MMR) vaccine, and the vaccines for polio, rotavirus, and varicella, which can cause the diseases they are supposed to prevent. […] Immunoglobulin replacement therapy reduces the risk of invasive infection. Chronic lung disease still develops and overall survival is reduced.
#25 X-linked-agammaglobulinaemia
https://dermnetnz.org/topics/x-linked-agammaglobulinaemia
There is no cure for X-linked agammaglobulinaemia. However, treatment can greatly improve quality of life for X-linked agammaglobulinaemia patients. […] Life-long immunoglobulin replacement therapy, given intravenously or subcutaneously. This helps replace antibodies an X-linked agammaglobulinaemia patient cannot make for themselves. […] Antibiotics sometimes used prophylactically to reduce infection rates. […] Avoid live vaccines including measles, mumps, and rubella (MMR) vaccine, and the vaccines for polio, rotavirus, and varicella, which can cause the diseases they are supposed to prevent. […] Immunoglobulin replacement therapy reduces the risk of invasive infection. Chronic lung disease still develops and overall survival is reduced.
#26 X-Linked Agammaglobulinemia – MD Searchlight
https://mdsearchlight.com/genetic-disorders/x-linked-agammaglobulinemia/?utm_source=pubmedlink&utm_campaign=MDS&utm_content=31430
Patients are also advised about the importance of getting all the vaccinations that don’t contain live bacteria or viruses. […] The side effects of immunoglobulin therapy can vary but are often not severe and only temporary. Symptoms can include headaches, fever, muscle pain, changes in blood pressure, nausea, and chest discomfort. […] Patients with XLA rely on regular replacement of immunoglobulins, specific proteins that our immune system uses to fight off bacteria and viruses. […] Doctors can manage these side effects by altering parameters involved in the immunoglobulin replacement therapy, such as the time between infusions, the method of administration, the delivery rate, and the specific product used for replacement. […] Keeping records of all aspects of patient care, care management, and follow-up details is encouraged.
#27 X-linked agammaglobulinemia – Diagnosis and treatment – Mayo Clinic
https://www.mayoclinic.org/diseases-conditions/x-linked-agammaglobulinemia/diagnosis-treatment/drc-20361639
Our caring team of Mayo Clinic experts can help you with your X-linked agammaglobulinemia-related health concerns […] Your healthcare professional likely will suggest that you have follow-up visits every 6 to 12 months to screen for complications of XLA. You’ll also likely be told to not get live vaccines, such as live polio, measles-mumps-rubella or chickenpox vaccines.
#28 X-linked agammaglobulinemia – Hancock Health
https://www.hancockhealth.org/mayo-health-library/x-linked-agammaglobulinemia/
X-linked agammaglobulinemia is caused by a change in a gene. People with the condition cant produce proteins called antibodies that fight infection. […] People with XLA can live mostly typical lives. They should try to take part in regular activities for their ages. But repeat infections linked to XLA will likely need careful watching and treatment. They can damage organs and be life-threatening. […] Theres no cure for XLA. Treatment aims at boosting the immune system to prevent infections. There also is quick treatment for infections as they happen. […] Your healthcare professional likely will suggest that you have follow-up visits every 6 to 12 months to screen for complications of XLA. Youll also likely be told to not get live vaccines, such as live polio, measles-mumps-rubella or chickenpox vaccines.
#29 X-Linked Agammaglobulinemia in Children
https://myhealth.umassmemorial.org/YourFamily/Children/90,P01666
Most children with X-linked agammaglobulinemia who are treated early can lead normal, active lives. […] Treatment may include replacing antibodies, treating and preventing infections, and not getting live virus vaccines. […] Keep in regular touch with your child’s healthcare provider, and tell your child’s school and other close contacts. This will help your child stay healthier. […] Be sure to: Keep all appointments with your child’s healthcare provider. […] Call your child’s healthcare provider if you are concerned about your child’s symptoms. […] Practice good infection prevention habits, such as handwashing and keeping your child away from others with infections. […] Tell others of your child’s condition. Work with your child’s healthcare provider and school to come up with a treatment plan.
#30 X-Linked Agammaglobulinemia | Treatment & Management | Point of Care
https://www.statpearls.com/point-of-care/31430
X-linked agammaglobulinemia or XLA is one of the most common pediatric primary immunodeficiencies that prevent affected individuals from making antibodies and requires lifelong immunoglobulin replacement therapy for survival. […] There is currently no cure for XLA; however, early management with immunoglobulin replacement therapy and antibiotics to prevent and treat infections. […] The optimal management of patients with XLA includes regular immunoglobulin replacement therapy, using intravenous or subcutaneous infusions. […] The current mainstay of treatment is with intravenous immunoglobulin. […] Patients and their families should be provided resources and educational materials informing them about vaccines, immunoglobulin replacement therapy, prophylactic and therapeutic use of antibiotics, routine and emergency medical care, the importance of keeping follow-up appointments, healthcare team specialists, preparation for traveling, the importance of record-keeping, support, and how to become a good patient advocate. […] Early diagnosis is key in decreasing morbidity and mortality of patients with XLA. […] Overall, an interprofessional team approach to the treatment of patients with XLA is the proper management methodology.
#31 X-Linked Agammaglobulinemia | Treatment & Management | Point of Care
https://www.statpearls.com/point-of-care/31430
X-linked agammaglobulinemia or XLA is one of the most common pediatric primary immunodeficiencies that prevent affected individuals from making antibodies and requires lifelong immunoglobulin replacement therapy for survival. […] There is currently no cure for XLA; however, early management with immunoglobulin replacement therapy and antibiotics to prevent and treat infections. […] The optimal management of patients with XLA includes regular immunoglobulin replacement therapy, using intravenous or subcutaneous infusions. […] The current mainstay of treatment is with intravenous immunoglobulin. […] Patients and their families should be provided resources and educational materials informing them about vaccines, immunoglobulin replacement therapy, prophylactic and therapeutic use of antibiotics, routine and emergency medical care, the importance of keeping follow-up appointments, healthcare team specialists, preparation for traveling, the importance of record-keeping, support, and how to become a good patient advocate. […] Early diagnosis is key in decreasing morbidity and mortality of patients with XLA. […] Overall, an interprofessional team approach to the treatment of patients with XLA is the proper management methodology.
#32 X-Linked Agammaglobulinemia in Children
https://myhealth.umassmemorial.org/YourFamily/Children/90,P01666
Most children with X-linked agammaglobulinemia who are treated early can lead normal, active lives. […] Treatment may include replacing antibodies, treating and preventing infections, and not getting live virus vaccines. […] Keep in regular touch with your child’s healthcare provider, and tell your child’s school and other close contacts. This will help your child stay healthier. […] Be sure to: Keep all appointments with your child’s healthcare provider. […] Call your child’s healthcare provider if you are concerned about your child’s symptoms. […] Practice good infection prevention habits, such as handwashing and keeping your child away from others with infections. […] Tell others of your child’s condition. Work with your child’s healthcare provider and school to come up with a treatment plan.
#33 X-Linked Agammaglobulinemia in Children
https://myhealth.umassmemorial.org/YourFamily/Children/90,P01666
Most children with X-linked agammaglobulinemia who are treated early can lead normal, active lives. […] Treatment may include replacing antibodies, treating and preventing infections, and not getting live virus vaccines. […] Keep in regular touch with your child’s healthcare provider, and tell your child’s school and other close contacts. This will help your child stay healthier. […] Be sure to: Keep all appointments with your child’s healthcare provider. […] Call your child’s healthcare provider if you are concerned about your child’s symptoms. […] Practice good infection prevention habits, such as handwashing and keeping your child away from others with infections. […] Tell others of your child’s condition. Work with your child’s healthcare provider and school to come up with a treatment plan.
#34 X-Linked Agammaglobulinemia: Causes, Symptoms & Treatment
https://my.clevelandclinic.org/health/diseases/24955-x-linked-agammaglobulinemia
X-linked agammaglobulinemia (XLA) is a condition caused by a mutation in your BTK gene. Treatment for XLA includes antibody infusions. […] A healthcare provider can perform blood tests to determine whether you or your child have XLA. If test results show a low level of B-cells or antibodies, they’ll do genetic testing to look for DNA changes. […] There’s no cure for XLA. But treatments can help you or your child avoid serious illness. They include: Replacement immunoglobulins (RIgG). Your healthcare provider gives you donor antibodies in a vein. You’ll need this treatment at least once per month. […] The best way to take care of yourself with XLA is to prioritize your care. Keep appointments with your provider, and make sure you can recognize signs of an infection. Ask your provider what to do if you have symptoms of an infection. […] If you’re living with XLA a genetic condition where your body doesn’t make enough mature B-cells follow your healthcare provider’s guidance about when you may need care. It’s important that you can recognize signs of an infection so you can get treated as soon as possible.
#35 X-Linked Agammaglobulinemia | Treatment & Management | Point of Care
https://www.statpearls.com/point-of-care/31430
X-linked agammaglobulinemia or XLA is one of the most common pediatric primary immunodeficiencies that prevent affected individuals from making antibodies and requires lifelong immunoglobulin replacement therapy for survival. […] There is currently no cure for XLA; however, early management with immunoglobulin replacement therapy and antibiotics to prevent and treat infections. […] The optimal management of patients with XLA includes regular immunoglobulin replacement therapy, using intravenous or subcutaneous infusions. […] The current mainstay of treatment is with intravenous immunoglobulin. […] Patients and their families should be provided resources and educational materials informing them about vaccines, immunoglobulin replacement therapy, prophylactic and therapeutic use of antibiotics, routine and emergency medical care, the importance of keeping follow-up appointments, healthcare team specialists, preparation for traveling, the importance of record-keeping, support, and how to become a good patient advocate. […] Early diagnosis is key in decreasing morbidity and mortality of patients with XLA. […] Overall, an interprofessional team approach to the treatment of patients with XLA is the proper management methodology.
#36 X-linked agammaglobulinemia – Symptoms and causes – Mayo Clinic
https://www.mayoclinic.org/diseases-conditions/x-linked-agammaglobulinemia/symptoms-causes/syc-20361635
X-linked agammaglobulinemia care at Mayo Clinic […] People with XLA can live mostly typical lives. They should try to take part in regular activities for their ages. But repeat infections linked to XLA will likely need careful watching and treatment. They can damage organs and be life-threatening.
#37 X-linked agammaglobulinemia | Beacon Health System
https://www.beaconhealthsystem.org/library/diseases-and-conditions/x-linked-agammaglobulinemia?content_id=CON-20256723
This genetic disease weakens the immune system, mainly in males, and leads to having infections often. […] People with XLA can live mostly typical lives. They should try to take part in regular activities for their ages. But repeat infections linked to XLA will likely need careful watching and treatment. They can damage organs and be life-threatening. […] There’s no cure for XLA. Treatment aims at boosting the immune system to prevent infections. There also is quick treatment for infections as they happen. […] Your healthcare professional likely will suggest that you have follow-up visits every 6 to 12 months to screen for complications of XLA. You’ll also likely be told to not get live vaccines, such as live polio, measles-mumps-rubella or chickenpox vaccines.
#38 X-Linked Agammaglobulinemia in Children
https://library.sarahbush.org/MentalHealth/90,P01666
Most children with X-linked agammaglobulinemia who are treated early can lead normal, active lives. […] Treatment may include replacing antibodies, treating and preventing infections, and not getting live virus vaccines. […] Keep in regular touch with your child’s healthcare provider, and tell your child’s school and other close contacts. This will help your child stay healthier.
#39 X-Linked Agammaglobulinemia in Children
https://myhealth.umassmemorial.org/YourFamily/Children/90,P01666
Most children with X-linked agammaglobulinemia who are treated early can lead normal, active lives. […] Treatment may include replacing antibodies, treating and preventing infections, and not getting live virus vaccines. […] Keep in regular touch with your child’s healthcare provider, and tell your child’s school and other close contacts. This will help your child stay healthier. […] Be sure to: Keep all appointments with your child’s healthcare provider. […] Call your child’s healthcare provider if you are concerned about your child’s symptoms. […] Practice good infection prevention habits, such as handwashing and keeping your child away from others with infections. […] Tell others of your child’s condition. Work with your child’s healthcare provider and school to come up with a treatment plan.
#40 X-Linked Agammaglobulinemia in Children
https://myhealth.umassmemorial.org/YourFamily/Children/90,P01666
Most children with X-linked agammaglobulinemia who are treated early can lead normal, active lives. […] Treatment may include replacing antibodies, treating and preventing infections, and not getting live virus vaccines. […] Keep in regular touch with your child’s healthcare provider, and tell your child’s school and other close contacts. This will help your child stay healthier. […] Be sure to: Keep all appointments with your child’s healthcare provider. […] Call your child’s healthcare provider if you are concerned about your child’s symptoms. […] Practice good infection prevention habits, such as handwashing and keeping your child away from others with infections. […] Tell others of your child’s condition. Work with your child’s healthcare provider and school to come up with a treatment plan.
#41 X-Linked (Bruton) Agammaglobulinemia Treatment & Management: Medical Care, Surgical Care, Consultations
https://emedicine.medscape.com/article/1050956-treatment
Bronchodilators, steroid inhalers, and regular pulmonary function tests (at least 3-4 times a year) may be a required part of therapy in addition to antibiotics. […] Chronic dermatologic manifestations of atopic dermatitis and eczema are controlled with daily moisturizing lotions and topical steroids. […] Nutritional supplementation with multivitamins is recommended. […] Patients with X-linked agammaglobulinemia (XLA), or Bruton agammaglobulinemia, are hospitalized for severe infections or acute decompensation. […] Immunologists are well equipped to treat the clinical illnesses of XLA. If a patient chooses to have health care provided by a primary care physician, the physician should have a special interest and experience in immunodeficiency diseases. […] Surgical intervention for X-linked agammaglobulinemia (XLA) is limited to severe acute infections or unresponsive chronic infections. The most common procedures involve treating patients with recurrent otitis by inserting tympanostomy tubes and treating patients with chronic sinusitis by surgical drainage.
#42 X-Linked (Bruton) Agammaglobulinemia Treatment & Management: Medical Care, Surgical Care, Consultations
https://emedicine.medscape.com/article/1050956-treatment
Bronchodilators, steroid inhalers, and regular pulmonary function tests (at least 3-4 times a year) may be a required part of therapy in addition to antibiotics. […] Chronic dermatologic manifestations of atopic dermatitis and eczema are controlled with daily moisturizing lotions and topical steroids. […] Nutritional supplementation with multivitamins is recommended. […] Patients with X-linked agammaglobulinemia (XLA), or Bruton agammaglobulinemia, are hospitalized for severe infections or acute decompensation. […] Immunologists are well equipped to treat the clinical illnesses of XLA. If a patient chooses to have health care provided by a primary care physician, the physician should have a special interest and experience in immunodeficiency diseases. […] Surgical intervention for X-linked agammaglobulinemia (XLA) is limited to severe acute infections or unresponsive chronic infections. The most common procedures involve treating patients with recurrent otitis by inserting tympanostomy tubes and treating patients with chronic sinusitis by surgical drainage.
#43 X-Linked (Bruton) Agammaglobulinemia Treatment & Management: Medical Care, Surgical Care, Consultations
https://emedicine.medscape.com/article/1050956-treatment
Bronchodilators, steroid inhalers, and regular pulmonary function tests (at least 3-4 times a year) may be a required part of therapy in addition to antibiotics. […] Chronic dermatologic manifestations of atopic dermatitis and eczema are controlled with daily moisturizing lotions and topical steroids. […] Nutritional supplementation with multivitamins is recommended. […] Patients with X-linked agammaglobulinemia (XLA), or Bruton agammaglobulinemia, are hospitalized for severe infections or acute decompensation. […] Immunologists are well equipped to treat the clinical illnesses of XLA. If a patient chooses to have health care provided by a primary care physician, the physician should have a special interest and experience in immunodeficiency diseases. […] Surgical intervention for X-linked agammaglobulinemia (XLA) is limited to severe acute infections or unresponsive chronic infections. The most common procedures involve treating patients with recurrent otitis by inserting tympanostomy tubes and treating patients with chronic sinusitis by surgical drainage.
#44 X-Linked (Bruton) Agammaglobulinemia Treatment & Management: Medical Care, Surgical Care, Consultations
https://emedicine.medscape.com/article/1050956-treatment
Special concerns for patients with XLA arise preceding surgery. In this situation, intravenous immunoglobulin (IVIG) is preoperatively administered to prevent infection. Live vaccines must be withheld. […] Patients with XLA should follow their normal diet supplemented by a multivitamin. No dietary limitations are specific for XLA, although a low-fat diet may be needed for patients with inflammatory bowel disease. […] Patients with XLA have no specific physical limitations. Not smoking or not being exposed to smoke is strongly recommended for patients because of the increased risk of sinopulmonary infection. […] Patients with XLA are treated well medically as outpatients. Treatments with IVIG and necessary antibiotics for infections are all provided on an outpatient basis. Most tests and evaluations can be performed and most medications can be administered on an outpatient basis.
#45 Mycoplasma pneumonia in a patient with X-linked agammaglobulinemia | BMC Infectious Diseases | Full Text
https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-024-09743-w
X-linked agammaglobulinemia (XLA), also referred to as Brutons tyrosine kinase deficiency, is a rare genetic disorder that affects the immune system. […] We emphasize the importance of increased importance of early diagnosis of XLA so that patients can begin treatment quickly. […] Common complications of XLA include otitis media, sinusitis, and pneumonia, which require immediate diagnostic assessment and therapeutic intervention to prevent further complications. […] Given the absence of targeted XLA treatments, patients typically receive immunoglobulin replacements and use antibiotics prophylactically to prevent recurrent infections. […] Mycoplasma pneumoniae, a prominent etiological cause of community-acquired pneumonia, particularly affects children with immunodeficiency, often resulting in more severe illness.
#46 X-linked agammaglobulinemia (XLA) – Children’s Health Immunology
https://www.childrens.com/specialties-services/conditions/xla
If your child is diagnosed with XLA, they will be treated with immunoglobulin IgG (antibodies) therapy on a regular basis for the rest of his life. IgG therapy can be given through a catheter in your childs vein (intravenous; IVIG) or subcutaneously (SCIG). The decision to use one or the other depends on whats best for your child and your family. There is currently no cure for XLA. […] Children with XLA should be followed at the center. If your child develops an infection, antibiotics can treat the infection. Some patients with XLA may have complications including gastrointestinal problems that may require cooperative interaction with gastroenterology specialists.
#47 X-linked-agammaglobulinaemia
https://dermnetnz.org/topics/x-linked-agammaglobulinaemia
There is no cure for X-linked agammaglobulinaemia. However, treatment can greatly improve quality of life for X-linked agammaglobulinaemia patients. […] Life-long immunoglobulin replacement therapy, given intravenously or subcutaneously. This helps replace antibodies an X-linked agammaglobulinaemia patient cannot make for themselves. […] Antibiotics sometimes used prophylactically to reduce infection rates. […] Avoid live vaccines including measles, mumps, and rubella (MMR) vaccine, and the vaccines for polio, rotavirus, and varicella, which can cause the diseases they are supposed to prevent. […] Immunoglobulin replacement therapy reduces the risk of invasive infection. Chronic lung disease still develops and overall survival is reduced.
#48 X-Linked (Bruton) Agammaglobulinemia Treatment & Management: Medical Care, Surgical Care, Consultations
https://emedicine.medscape.com/article/1050956-treatment
Special concerns for patients with XLA arise preceding surgery. In this situation, intravenous immunoglobulin (IVIG) is preoperatively administered to prevent infection. Live vaccines must be withheld. […] Patients with XLA should follow their normal diet supplemented by a multivitamin. No dietary limitations are specific for XLA, although a low-fat diet may be needed for patients with inflammatory bowel disease. […] Patients with XLA have no specific physical limitations. Not smoking or not being exposed to smoke is strongly recommended for patients because of the increased risk of sinopulmonary infection. […] Patients with XLA are treated well medically as outpatients. Treatments with IVIG and necessary antibiotics for infections are all provided on an outpatient basis. Most tests and evaluations can be performed and most medications can be administered on an outpatient basis.
#49 X-Linked (Bruton) Agammaglobulinemia Treatment & Management: Medical Care, Surgical Care, Consultations
https://emedicine.medscape.com/article/1050956-treatment
Bronchodilators, steroid inhalers, and regular pulmonary function tests (at least 3-4 times a year) may be a required part of therapy in addition to antibiotics. […] Chronic dermatologic manifestations of atopic dermatitis and eczema are controlled with daily moisturizing lotions and topical steroids. […] Nutritional supplementation with multivitamins is recommended. […] Patients with X-linked agammaglobulinemia (XLA), or Bruton agammaglobulinemia, are hospitalized for severe infections or acute decompensation. […] Immunologists are well equipped to treat the clinical illnesses of XLA. If a patient chooses to have health care provided by a primary care physician, the physician should have a special interest and experience in immunodeficiency diseases. […] Surgical intervention for X-linked agammaglobulinemia (XLA) is limited to severe acute infections or unresponsive chronic infections. The most common procedures involve treating patients with recurrent otitis by inserting tympanostomy tubes and treating patients with chronic sinusitis by surgical drainage.
#50 X-Linked (Bruton) Agammaglobulinemia Treatment & Management: Medical Care, Surgical Care, Consultations
https://emedicine.medscape.com/article/1050956-treatment
Special concerns for patients with XLA arise preceding surgery. In this situation, intravenous immunoglobulin (IVIG) is preoperatively administered to prevent infection. Live vaccines must be withheld. […] Patients with XLA should follow their normal diet supplemented by a multivitamin. No dietary limitations are specific for XLA, although a low-fat diet may be needed for patients with inflammatory bowel disease. […] Patients with XLA have no specific physical limitations. Not smoking or not being exposed to smoke is strongly recommended for patients because of the increased risk of sinopulmonary infection. […] Patients with XLA are treated well medically as outpatients. Treatments with IVIG and necessary antibiotics for infections are all provided on an outpatient basis. Most tests and evaluations can be performed and most medications can be administered on an outpatient basis.
#51 X-linked agammaglobulinemia – Symptoms and causes – Mayo Clinic
https://www.mayoclinic.org/diseases-conditions/x-linked-agammaglobulinemia/symptoms-causes/syc-20361635
X-linked agammaglobulinemia care at Mayo Clinic […] People with XLA can live mostly typical lives. They should try to take part in regular activities for their ages. But repeat infections linked to XLA will likely need careful watching and treatment. They can damage organs and be life-threatening.
#52 X-Linked Agammaglobulinemia | Treatment & Management | Point of Care
https://www.statpearls.com/point-of-care/31430
X-linked agammaglobulinemia or XLA is one of the most common pediatric primary immunodeficiencies that prevent affected individuals from making antibodies and requires lifelong immunoglobulin replacement therapy for survival. […] There is currently no cure for XLA; however, early management with immunoglobulin replacement therapy and antibiotics to prevent and treat infections. […] The optimal management of patients with XLA includes regular immunoglobulin replacement therapy, using intravenous or subcutaneous infusions. […] The current mainstay of treatment is with intravenous immunoglobulin. […] Patients and their families should be provided resources and educational materials informing them about vaccines, immunoglobulin replacement therapy, prophylactic and therapeutic use of antibiotics, routine and emergency medical care, the importance of keeping follow-up appointments, healthcare team specialists, preparation for traveling, the importance of record-keeping, support, and how to become a good patient advocate. […] Early diagnosis is key in decreasing morbidity and mortality of patients with XLA. […] Overall, an interprofessional team approach to the treatment of patients with XLA is the proper management methodology.
#53 X-Linked (Bruton) Agammaglobulinemia Treatment & Management: Medical Care, Surgical Care, Consultations
https://emedicine.medscape.com/article/1050956-treatment
Bronchodilators, steroid inhalers, and regular pulmonary function tests (at least 3-4 times a year) may be a required part of therapy in addition to antibiotics. […] Chronic dermatologic manifestations of atopic dermatitis and eczema are controlled with daily moisturizing lotions and topical steroids. […] Nutritional supplementation with multivitamins is recommended. […] Patients with X-linked agammaglobulinemia (XLA), or Bruton agammaglobulinemia, are hospitalized for severe infections or acute decompensation. […] Immunologists are well equipped to treat the clinical illnesses of XLA. If a patient chooses to have health care provided by a primary care physician, the physician should have a special interest and experience in immunodeficiency diseases. […] Surgical intervention for X-linked agammaglobulinemia (XLA) is limited to severe acute infections or unresponsive chronic infections. The most common procedures involve treating patients with recurrent otitis by inserting tympanostomy tubes and treating patients with chronic sinusitis by surgical drainage.
#54 Mycoplasma pneumonia in a patient with X-linked agammaglobulinemia | BMC Infectious Diseases | Full Text
https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-024-09743-w
Following immunoglobulin treatment, the patients condition gradually improved. However, given the chronic nature of XLA, lifelong administration of immunoglobulins and additional interventions to manage infections or other complications are likely necessary. Regular monitoring and provision of supportive care are essential for optimal management of XLA. […] To minimize the risk of misdiagnosis, clinicians should maintain a high suspicion for XLA in patients who experience recurrent infections and have a suggestive family history. […] Early diagnosis would be beneficial for the improvement of their quality of life. […] By identifying the specific gene mutations responsible for XLA, healthcare professionals can provide targeted treatments and interventions to manage the condition effectively. […] In conclusion, the prognosis for patients with XLA can be favorably impacted through prompt diagnosis and the judicious use of immunoglobulin therapy. […] Health care providers are aware of the increased importance of early diagnosis of XLA so that patients can begin treatment quickly.
#55 X-Linked Agammaglobulinemia in Children
https://library.sarahbush.org/MentalHealth/90,P01666
Most children with X-linked agammaglobulinemia who are treated early can lead normal, active lives. […] Treatment may include replacing antibodies, treating and preventing infections, and not getting live virus vaccines. […] Keep in regular touch with your child’s healthcare provider, and tell your child’s school and other close contacts. This will help your child stay healthier.
#56 X-Linked Agammaglobulinemia in Children
https://phoenixchildrens.staywellsolutionsonline.com/Library/DiseasesConditions/Pediatric/Blood/90,P01666
X-linked agammaglobulinemia is a rare genetic disease. It causes a weakened immune system. […] Most children with this disease who are treated early can lead normal, active lives. […] Treatment may include replacing antibodies, treating and preventing infections, and not getting live virus vaccines. […] Keep in regular touch with your child’s healthcare provider, and tell your child’s school and other close contacts. This will help your child stay healthier.
#57 X-linked-agammaglobulinaemia
https://dermnetnz.org/topics/x-linked-agammaglobulinaemia
There is no cure for X-linked agammaglobulinaemia. However, treatment can greatly improve quality of life for X-linked agammaglobulinaemia patients. […] Life-long immunoglobulin replacement therapy, given intravenously or subcutaneously. This helps replace antibodies an X-linked agammaglobulinaemia patient cannot make for themselves. […] Antibiotics sometimes used prophylactically to reduce infection rates. […] Avoid live vaccines including measles, mumps, and rubella (MMR) vaccine, and the vaccines for polio, rotavirus, and varicella, which can cause the diseases they are supposed to prevent. […] Immunoglobulin replacement therapy reduces the risk of invasive infection. Chronic lung disease still develops and overall survival is reduced.
#58 Mycoplasma pneumonia in a patient with X-linked agammaglobulinemia | BMC Infectious Diseases | Full Text
https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-024-09743-w
Following immunoglobulin treatment, the patients condition gradually improved. However, given the chronic nature of XLA, lifelong administration of immunoglobulins and additional interventions to manage infections or other complications are likely necessary. Regular monitoring and provision of supportive care are essential for optimal management of XLA. […] To minimize the risk of misdiagnosis, clinicians should maintain a high suspicion for XLA in patients who experience recurrent infections and have a suggestive family history. […] Early diagnosis would be beneficial for the improvement of their quality of life. […] By identifying the specific gene mutations responsible for XLA, healthcare professionals can provide targeted treatments and interventions to manage the condition effectively. […] In conclusion, the prognosis for patients with XLA can be favorably impacted through prompt diagnosis and the judicious use of immunoglobulin therapy. […] Health care providers are aware of the increased importance of early diagnosis of XLA so that patients can begin treatment quickly.
#59 X-Linked Agammaglobulinemia | Treatment & Management | Point of Care
https://www.statpearls.com/point-of-care/31430
X-linked agammaglobulinemia or XLA is one of the most common pediatric primary immunodeficiencies that prevent affected individuals from making antibodies and requires lifelong immunoglobulin replacement therapy for survival. […] There is currently no cure for XLA; however, early management with immunoglobulin replacement therapy and antibiotics to prevent and treat infections. […] The optimal management of patients with XLA includes regular immunoglobulin replacement therapy, using intravenous or subcutaneous infusions. […] The current mainstay of treatment is with intravenous immunoglobulin. […] Patients and their families should be provided resources and educational materials informing them about vaccines, immunoglobulin replacement therapy, prophylactic and therapeutic use of antibiotics, routine and emergency medical care, the importance of keeping follow-up appointments, healthcare team specialists, preparation for traveling, the importance of record-keeping, support, and how to become a good patient advocate. […] Early diagnosis is key in decreasing morbidity and mortality of patients with XLA. […] Overall, an interprofessional team approach to the treatment of patients with XLA is the proper management methodology.
#60 Mycoplasma pneumonia in a patient with X-linked agammaglobulinemia | BMC Infectious Diseases | Full Text
https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-024-09743-w
Following immunoglobulin treatment, the patients condition gradually improved. However, given the chronic nature of XLA, lifelong administration of immunoglobulins and additional interventions to manage infections or other complications are likely necessary. Regular monitoring and provision of supportive care are essential for optimal management of XLA. […] To minimize the risk of misdiagnosis, clinicians should maintain a high suspicion for XLA in patients who experience recurrent infections and have a suggestive family history. […] Early diagnosis would be beneficial for the improvement of their quality of life. […] By identifying the specific gene mutations responsible for XLA, healthcare professionals can provide targeted treatments and interventions to manage the condition effectively. […] In conclusion, the prognosis for patients with XLA can be favorably impacted through prompt diagnosis and the judicious use of immunoglobulin therapy. […] Health care providers are aware of the increased importance of early diagnosis of XLA so that patients can begin treatment quickly.